CLINICAL_TRIALS
trial_result
· 2016-02-11
Clinical Trial Update: A Study of RO5185426 in Patients With Metastatic Melanoma [Phase 2]
Summary
Phase 2 study of RO5185426 in metastatic melanoma has completed, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2016-02-11